BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11494140)

  • 1. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
    Zhang Z; DuBois RN
    Oncogene; 2001 Jul; 20(33):4450-6. PubMed ID: 11494140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.
    Ferris WF
    Front Oncol; 2022; 12():903374. PubMed ID: 35847932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of rectal cancer-related lncRNA-mRNA ceRNA network reveals prognostic biomarkers in rectal cancer.
    Cai G; Sun M; Li X; Zhu J
    IET Syst Biol; 2021 Aug; 15(6):192-204. PubMed ID: 34613665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via
    Youns M; Askoura M; Abbas HA; Attia GH; Khayyat AN; Goda RM; Almalki AJ; Khafagy ES; Hegazy WAH
    Onco Targets Ther; 2021; 14():3849-3860. PubMed ID: 34194230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Modulation of Host Immune Response and Inflammation Triggered by
    Săsăran MO; Meliț LE; Dobru ED
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573346
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.
    Hidalgo-Estévez AM; Stamatakis K; Jiménez-Martínez M; López-Pérez R; Fresno M
    Front Pharmacol; 2020; 11():533. PubMed ID: 32410997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers.
    Maust JD; Frankowski-McGregor CL; Bankhead A; Simeone DM; Sebolt-Leopold JS
    Mol Cancer Ther; 2018 Dec; 17(12):2495-2506. PubMed ID: 30254182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1.
    Zhao J; Cao J; Zhou L; Du Y; Zhang X; Yang B; Gao Y; Wang Y; Ma N; Yang W
    Oncol Lett; 2018 Oct; 16(4):5131-5139. PubMed ID: 30250581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth inhibitory effect of gambogic acid on pancreatic cancer cells.
    Youns M; ElKhoely A; Kamel R
    Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):551-560. PubMed ID: 29546614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data.
    Ge C; Wu M; Chen G; Yu G; Ji D; Wang S
    Oncol Lett; 2017 Apr; 13(4):2777-2783. PubMed ID: 28454466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.
    Gu W; Gao T; Shen J; Sun Y; Zheng X; Wang J; Ma J; Hu XY; Li J; Hu MJ
    Int J Clin Exp Med; 2014; 7(9):2519-29. PubMed ID: 25356105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer.
    Peacock O; Lee AC; Cameron F; Tarbox R; Vafadar-Isfahani N; Tufarelli C; Lund JN
    PLoS One; 2014; 9(10):e110267. PubMed ID: 25310697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.
    Huang Y; Liu Y; Yu L; Chen J; Hou J; Cui L; Ma D; Lu W
    Tumour Biol; 2015 Jan; 36(1):271-8. PubMed ID: 25245333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.
    Aryee DN; Niedan S; Ban J; Schwentner R; Muehlbacher K; Kauer M; Kofler R; Kovar H
    Br J Cancer; 2013 Nov; 109(10):2696-704. PubMed ID: 24129240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers.
    Ma G; Zhang H; Dong M; Zheng X; Ozaki I; Matsuhashi S; Guo K
    Tumour Biol; 2013 Dec; 34(6):3879-85. PubMed ID: 23838800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5.
    Song X; Zhang X; Wang X; Zhu F; Guo C; Wang Q; Shi Y; Wang J; Chen Y; Zhang L
    Autophagy; 2013 May; 9(5):743-55. PubMed ID: 23486359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo optical molecular imaging of matrix metalloproteinase activity following celecoxib therapy for colorectal cancer.
    Sheth RA; Kunin A; Stangenberg L; Sinnamon M; Hung KE; Kucherlapati R; Mahmood U
    Mol Imaging; 2012; 11(5):417-25. PubMed ID: 22954186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase 2 inhibitors and colon cancer.
    Gonzalez-Angulo AM; Fuloria J; Prakash O
    Ochsner J; 2002; 4(3):176-9. PubMed ID: 22822342
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards universal screening for colon cancer: a cheap, reliable, noninvasive test using gene expression analysis of rectal swabs.
    Smith AP; Chiu YS; Lee NM
    ISRN Gastroenterol; 2012; 2012():170210. PubMed ID: 22461995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.